Matches in SemOpenAlex for { <https://semopenalex.org/work/W3215678329> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- W3215678329 abstract "<b>Background:</b> Asthma is the most common chronic respiratory condition in children, who may have uncontrolled disease despite maximal therapy. Type 2 (T2) inflammation (blood eosinophils ≥150 cells/µL or FeNO ≥20 ppb) underlies most pediatric asthma. Dupilumab (DPL), a fully human mAb, blocks the shared receptor component for IL-4/13, key and central drivers of T2 inflammation. VOYAGE, a 52-week randomized, double-blind, placebo (PBO)-controlled phase 3 study (NCT02948959), evaluated DPL efficacy/safety in children aged 6–11 years with uncontrolled persistent asthma. <b>Aim:</b> Assess DPL impact on asthma control (ACQ-7-IA) and health-related quality of life (HRQoL; PAQLQ[S]-IA) in VOYAGE T2 patients (pts). <b>Methods:</b> Change from baseline in ACQ-7-IA/PAQLQ[S]-IA scores, percentage of responders (improvement ≥0.5) or pts who achieved well-controlled asthma (ACQ-7-IA score ≤0.75). <b>Results:</b> DPL vs PBO rapidly improved asthma control by Week (Wk)4 and was sustained to Wk52 (<i>P</i><0.05). At Wk24, 79% DPL vs 69% PBO pts were ACQ-7-IA responders and 61% DPL vs 43% PBO achieved well-controlled asthma (<i>P</i><0.05). From Wk36, DPL vs PBO significantly improved PAQLQ[S]-IA scores across all domains—symptoms, activity limitation, emotional. A higher proportion of DPL vs PBO pts were PAQLQ[S]-IA responders at Wk52 (<i>P</i><0.05; <b>Figure</b>). <b>Conclusion:</b> In children with uncontrolled T2 asthma, DPL rapidly improved asthma control. HRQoL also improved over time." @default.
- W3215678329 created "2021-12-06" @default.
- W3215678329 creator A5039452184 @default.
- W3215678329 creator A5043763838 @default.
- W3215678329 creator A5044544424 @default.
- W3215678329 creator A5045980264 @default.
- W3215678329 creator A5050993312 @default.
- W3215678329 creator A5052012397 @default.
- W3215678329 creator A5057913208 @default.
- W3215678329 creator A5087138210 @default.
- W3215678329 creator A5087200735 @default.
- W3215678329 creator A5089685782 @default.
- W3215678329 date "2021-09-05" @default.
- W3215678329 modified "2023-09-27" @default.
- W3215678329 title "Dupilumab improves asthma control and quality of life in children with uncontrolled persistent asthma" @default.
- W3215678329 doi "https://doi.org/10.1183/13993003.congress-2021.pa3920" @default.
- W3215678329 hasPublicationYear "2021" @default.
- W3215678329 type Work @default.
- W3215678329 sameAs 3215678329 @default.
- W3215678329 citedByCount "1" @default.
- W3215678329 countsByYear W32156783292022 @default.
- W3215678329 crossrefType "proceedings-article" @default.
- W3215678329 hasAuthorship W3215678329A5039452184 @default.
- W3215678329 hasAuthorship W3215678329A5043763838 @default.
- W3215678329 hasAuthorship W3215678329A5044544424 @default.
- W3215678329 hasAuthorship W3215678329A5045980264 @default.
- W3215678329 hasAuthorship W3215678329A5050993312 @default.
- W3215678329 hasAuthorship W3215678329A5052012397 @default.
- W3215678329 hasAuthorship W3215678329A5057913208 @default.
- W3215678329 hasAuthorship W3215678329A5087138210 @default.
- W3215678329 hasAuthorship W3215678329A5087200735 @default.
- W3215678329 hasAuthorship W3215678329A5089685782 @default.
- W3215678329 hasConcept C126322002 @default.
- W3215678329 hasConcept C142724271 @default.
- W3215678329 hasConcept C159110408 @default.
- W3215678329 hasConcept C187212893 @default.
- W3215678329 hasConcept C204787440 @default.
- W3215678329 hasConcept C27081682 @default.
- W3215678329 hasConcept C2776042228 @default.
- W3215678329 hasConcept C2779951463 @default.
- W3215678329 hasConcept C71924100 @default.
- W3215678329 hasConcept C90924648 @default.
- W3215678329 hasConceptScore W3215678329C126322002 @default.
- W3215678329 hasConceptScore W3215678329C142724271 @default.
- W3215678329 hasConceptScore W3215678329C159110408 @default.
- W3215678329 hasConceptScore W3215678329C187212893 @default.
- W3215678329 hasConceptScore W3215678329C204787440 @default.
- W3215678329 hasConceptScore W3215678329C27081682 @default.
- W3215678329 hasConceptScore W3215678329C2776042228 @default.
- W3215678329 hasConceptScore W3215678329C2779951463 @default.
- W3215678329 hasConceptScore W3215678329C71924100 @default.
- W3215678329 hasConceptScore W3215678329C90924648 @default.
- W3215678329 hasLocation W32156783291 @default.
- W3215678329 hasOpenAccess W3215678329 @default.
- W3215678329 hasPrimaryLocation W32156783291 @default.
- W3215678329 hasRelatedWork W1981307068 @default.
- W3215678329 hasRelatedWork W1986131348 @default.
- W3215678329 hasRelatedWork W2013851350 @default.
- W3215678329 hasRelatedWork W2052139239 @default.
- W3215678329 hasRelatedWork W2374430816 @default.
- W3215678329 hasRelatedWork W2407924119 @default.
- W3215678329 hasRelatedWork W2410569622 @default.
- W3215678329 hasRelatedWork W2416106402 @default.
- W3215678329 hasRelatedWork W4233016836 @default.
- W3215678329 hasRelatedWork W4235375593 @default.
- W3215678329 isParatext "false" @default.
- W3215678329 isRetracted "false" @default.
- W3215678329 magId "3215678329" @default.
- W3215678329 workType "article" @default.